Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fmoc Tyr(tBu). These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN116751139A eliminates hydrogenolysis for Fmoc-Tyr(tBu). Enhances safety and reduces costs for pharmaceutical intermediate manufacturing supply chains.
Novel Lewis acid hydrolysis route eliminates explosive isobutylene, ensuring high purity and supply chain safety for peptide synthesis intermediates.